2022
DOI: 10.1007/s10278-021-00570-y
|View full text |Cite
|
Sign up to set email alerts
|

BSREM for Brain Metastasis Detection with 18F-FDG-PET/CT in Lung Cancer Patients

Abstract: The aim of the study was to analyze the use of block sequential regularized expectation maximization (BSREM) with different β-values for the detection of brain metastases in digital fluorine-18 labeled 2-deoxy-2-fluoro-D-glucose (18F-FDG) PET/CT in lung cancer patients. We retrospectively analyzed staging/restaging 18F-FDG PET/CT scans of 40 consecutive lung cancer patients with new brain metastases, confirmed by MRI. PET images were reconstructed using BSREM (β-values of 100, 200, 300, 400, 500, 600, 700) and… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
7
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(8 citation statements)
references
References 61 publications
(78 reference statements)
0
7
0
Order By: Relevance
“…Different radiotracer characteristics likely influence the optimal β value. For example, β 400 for whole body 18 F-FDG [10], β 200-300 for brain metastasis [7], β 300 for whole body 18 F-fluciclovine [15]. This is likely due to the inherent imaging characteristics of 68 Ga tracers which result in increased imaged compared to fluorinated tracers.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Different radiotracer characteristics likely influence the optimal β value. For example, β 400 for whole body 18 F-FDG [10], β 200-300 for brain metastasis [7], β 300 for whole body 18 F-fluciclovine [15]. This is likely due to the inherent imaging characteristics of 68 Ga tracers which result in increased imaged compared to fluorinated tracers.…”
Section: Discussionmentioning
confidence: 99%
“…Our patient population was also heterogenous, including patients at different stages of their diagnosis, with different clinical indications for PSMA PET/CTs and with a wide variety of tumor-node-metastasis stages. Most of the studies to date have looked into the optimal β values for fluorinated PET tracers, with a few publications looking into the optimal β values in 18 F-FDG PET/CT imaging for pulmonary nodules [23,24] and brain metastases in lung cancer [7]; however, these do not translate well in real-world clinical practice, where patients come for a multitude of scan indications, and it would not be feasible to select different β values for different patients or even different regions of the body of the same patient. Blinding all readers to the β values and to one another's interpretation reduced the impact of bias.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…We compared its performance in terms of contrast recovery and noise suppression as well as quality of time-activity curves from relatively small structures to the performance achieved with all the available TOF reconstructions with point-spread-function (PSF) resolution modeling on the system, namely PSF-TOFOSEM with and without standard (3.5mm FWHM transaxial and 1-4-1 axial) post filter and PSF-TOFBSREM (i.e. TOF Q.Clear which is the newly introduced stateof-the-art clinical reconstruction method) [9,10] with various beta values (regularization strengths) using data acquired from contrast phantom and human subjects. In addition, the impact of the reconstruction method on the derivation of an image-derived input function (IDIF) obtained from a novel voxel search technique was investigated.…”
Section: Introductionmentioning
confidence: 99%
“…For example, the optimum β factor in 18F-fluorodeoxyglucose ( 18 F-FDG) PET has been reported between 300 and 500 for the whole-body scan [13,14] and between 100 to 200 for brain scans [14], 400-600 for pulmonary nodules [15,16], in Ga68 PSMA it is reported as 400-550 [17], for 18F-fluciclovine it is written as 300 [18] and 4000 for low count 90Y [19]. Further, most of the previous studies were performed in the time of flight (TOF)-based lutetium-yttrium oxyorthosilicate PET CT system [8,[14][15][16][18][19][20][21][22], and very few studies are available bismuth germanate oxide (BGO)-based fivering detector PET CT systems [13,23], and some recent studies are also conducted in PET MR [17,24,25]. Due to the recent use of BSREM reconstruction in scanners, its impact on clinical use and research applications is still being evaluated [21][22][23][24].…”
Section: Introductionmentioning
confidence: 99%